Literature DB >> 25078357

Germline mutation of Glu70Lys is highly frequent in Korean patients with von Hippel-Lindau (VHL) disease.

Sena Hwang1, Cheol Ryong Ku1, Ji In Lee2, Kyu Yeon Hur3, Myung-Shik Lee3, Chul-Ho Lee4, Kyo Yeon Koo4, Jin-Sung Lee4, Yumie Rhee1.   

Abstract

Von Hippel-Lindau (VHL) disease is an inherited tumor syndrome caused by germline mutations in the VHL tumor suppressor gene. It is characterized by hemangioblastoma in the central nervous system and retina, renal cell carcinoma, pancreatic tumor and cysts, and pheochromocytoma. In this study, we detected 26 germline mutations in the VHL gene of Korean patients, of which 1 was a novel mutation, c.417_418insT. We also integrated our data from this study with the published literature to identify 55 VHL germline mutations in Koreans, and identified a unique hotspot at codon 70. Nine unrelated patients (9/55, 16.4%) had the same amino-acid substitution at codon 70 (Glu70Lys) and showed VHL type 1 phenotypes. Although this mutation was shown to have a mild effect on VHL function, four of the nine patients (44.4%) subsequently developed multiple central nervous system hemangioblastomas or retinal hemangioblastoma. However, this hotspot has not been identified in Chinese or Japanese patients. This study provides information on the spectrum of VHL mutations in Korean VHL disease and contributes to a better understanding of VHL disease in terms of improvements in the clinical management of VHL families.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078357     DOI: 10.1038/jhg.2014.61

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  30 in total

1.  Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations.

Authors:  Sarah M Nielsen; Wendy S Rubinstein; Darcy L Thull; Michaele J Armstrong; Eleanor Feingold; Michael T Stang; James R Gnarra; Sally E Carty
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

2.  Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma.

Authors:  Alison C Young; Rachel A Craven; Dena Cohen; Claire Taylor; Christopher Booth; Patricia Harnden; David A Cairns; Dewi Astuti; Walter Gregory; Eamonn R Maher; Margaret A Knowles; Adrian Joyce; Peter J Selby; Rosamonde E Banks
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype.

Authors:  Pradeep Mettu; Elvira Agrón; Sonia Samtani; Emily Y Chew; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

4.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

5.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

6.  Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.

Authors:  S Olschwang; S Richard; C Boisson; S Giraud; P Laurent-Puig; F Resche; G Thomas
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

7.  Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.

Authors:  Zoran Erlic; Michael M Hoffmann; Maren Sullivan; Gerlind Franke; Mariola Peczkowska; Igor Harsch; Matthias Schott; Helmut E Gabbert; Matti Valimäki; Simon F Preuss; Kornelia Hasse-Lazar; Dariusz Waligorski; Mercedes Robledo; Andrzej Januszewicz; Charis Eng; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

8.  Malignant glioma arising at the site of an excised cerebellar hemangioblastoma after irradiation in a von Hippel-Lindau disease patient.

Authors:  Na-Hye Myong; Bong-Jin Park
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

9.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

10.  Germline mutations in the von Hippel-Lindau disease (VHL) gene in Japanese VHL. Clinical Research Group for VHL in Japan.

Authors: 
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

View more
  7 in total

1.  Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.

Authors:  Ping Yuan; Qipeng Sun; Hao Liang; Wenjun Wang; Ling Li; Ye Wang; Huan Deng; Luhua Lai; Xiaoli Chen; Xiangfu Zhou
Journal:  Cancer Biol Ther       Date:  2016-04-08       Impact factor: 4.742

2.  Genotype phenotype correlation in Asian Indian von Hippel-Lindau (VHL) syndrome patients with pheochromocytoma/paraganglioma.

Authors:  Nilesh Lomte; Sanjeet Kumar; Vijaya Sarathi; Reshma Pandit; Manjunath Goroshi; Swati Jadhav; Anurag R Lila; Tushar Bandgar; Nalini S Shah
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

3.  Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.

Authors:  Jee-Soo Lee; Ji-Hyun Lee; Kyu Eun Lee; Jung Hee Kim; Joon Mo Hong; Eun Kyung Ra; Soo Hyun Seo; Seung Jun Lee; Man Jin Kim; Sung Sup Park; Moon-Woo Seong
Journal:  BMC Med Genet       Date:  2016-07-20       Impact factor: 2.103

4.  Genetic Counseling and Long-Term Surveillance Using a Multidisciplinary Approach in von Hippel-Lindau Disease.

Authors:  Sun Joo Yoon; Won Kyung Kwon; Geehay Hong; Ja-Hyun Jang; Byong Chang Jeong; Jae Hyeon Kim; Jong-Won Kim
Journal:  Ann Lab Med       Date:  2022-05-01       Impact factor: 3.464

Review 5.  The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.

Authors:  Petra Hudler; Mojca Urbancic
Journal:  Genes (Basel)       Date:  2022-02-17       Impact factor: 4.096

Review 6.  Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.

Authors:  João Castro-Teles; Bernardo Sousa-Pinto; Sandra Rebelo; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2021-10-27       Impact factor: 3.335

7.  Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

Authors:  Baoan Hong; Kaifang Ma; Jingcheng Zhou; Jiufeng Zhang; Jiangyi Wang; Shengjie Liu; Zhongyuan Zhang; Lin Cai; Ning Zhang; Kan Gong
Journal:  Front Genet       Date:  2019-09-18       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.